The House passed FDA user fee legislation Wednesday afternoon (July 12) by voice vote, and lawmakers pressed the Senate to act quickly on the must-pass reauthorization package to avoid pink slips being sent to FDA employees at the end of the month. The White House, while supporting the goals of the overall package, raised concerns Wednesday (July 12) with the bill's new market exclusivity plan for generic drugs and lawmakers' refusal to heed the president’s call for industry to pay...